We are live on ! Find out more
PMN icon

ProMIS Neurosciences
PMN

15 hedge funds and large institutions have $6.49M invested in ProMIS Neurosciences in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.23% less ownership

Funds ownership: 29.73% → 28.49% (-1.2%)

12% less funds holding

Funds holding: 17 → 15 (-2)

30% less capital invested

Capital invested by funds: $9.21M → $6.49M (-$2.72M)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Allostery Investments
Connecticut
+$32.8K
2
FT
Fiduciary Trust
Massachusetts
+$4.25K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$149K
2
HCM
Heights Capital Management
California
-$121K
3
ABG
Ally Bridge Group
New York
-$91.6K
4
CAM
Claret Asset Management
Quebec, Canada
-$9.62K
5
ACM
Altium Capital Management
New York
-$6.07K

PMN Hedge Fund Activity: Q1 2025 in Review

15 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q1 2025, worth a combined $6.49M — down 30% from $9.21M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PMN and 0 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Allostery Investments, adding an estimated $32.8K. The largest seller was Armistice Capital, cutting an estimated $149K.

  • 15 institutional investors held ProMIS Neurosciences (PMN) as of Q1 2025, down from 17 in Q4 2024.
  • Funds reported $6.49M of ProMIS Neurosciences stock for Q1 2025, down 30% quarter-over-quarter.
  • 0 funds opened new ProMIS Neurosciences positions in Q1 2025 and 2 closed out, a net change of -2 holders.
  • The largest ProMIS Neurosciences buyer in Q1 2025 was Allostery Investments, an estimated $32.8K added.
  • The largest ProMIS Neurosciences seller in Q1 2025 was Armistice Capital, an estimated $149K sold.

Based on aggregated 13F filings for Q1 2025.